For researchers prioritizing maximum bioavailability and established protocol reliability, subcutaneous injection likely remains the preferred method
Best Practices for Subcutaneous Injection Choose a clean siteabdomen, outer thigh, or upper armand rotate daily to prevent irritation
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
34 people find this information helpful Disclaimer We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers
With our busy lifestyles, stress and fatigue can have a significant impact on our health, weight and wellbeing
Remember that early diagnosis and treatment offer the best chance of reversing nerve damage, so prompt medical consultation is always advisable when concerning symptoms develop